Julian Harrison is a Vice President and BTIG Biotechnology Analyst. Prior to BTIG, he was an Equity Research Associate at H.C. Wainwright & Co., covering small- to mid-cap biotechnology and specialty pharmaceutical companies. Previously, Mr. Harrison was a Clinical and Translational Research Assistant at Hospital for Special Surgery. He earned a BS in biology from Cornell University and an MS in health economics from Weill Cornell Medical College.
|Viking Therapeutics Inc||VKTX|
|Axcella Health Inc||AXLA|